Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigecycline versus ceftriaxone plus metronidazole for complicated intra-abdominal infection
2005-000448-99Phase 3Completed
- Sponsor
- Wyeth
- Start
- Aug 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tigecycline in Intra-abdominal infection (IAI) (2 arms), sponsored by Wyeth. Primary endpoint: Clinical response at test-of-cure. Started Aug 2005; status: completed.
02
Drugs
tigecycline
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on 2005-000448-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000448-99.